Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling

BackgroundEpithelial-mesenchymal transition (EMT) increases cell migration and is implicated in cancer cell invasion and metastasis. We have previously described the involvement of the transcription factors, nuclear factor I-C2 (NFI-C2) and Forkhead box F1 (FoxF1), in the regulation of EMT and invasion during breast tumor progression. NFI-C2 counteracts these processes and FoxF1 is a directly repressed target of NFI-C2. FoxF1 induces EMT and invasiveness and enhances xenograft tumorigenicity in nude mice. Here we identify oppositely regulated targets of NFI-C2 and FoxF1 involved in these processes and further study a possible role for FoxF1 in tumorigenesis.MethodsWe used Affymetrix microarray to detect changes in the transcriptome of a mouse mammary epithelial cell line upon overexpression of NFI-C2 or FoxF1. To elucidate the effects and signaling events following FoxF1 overexpression we investigated in vitro invasion capacity and changes in transcription and protein expression resulting from RNAi and inhibitor treatment.ResultsThe extracellular matrix enzyme lysyl oxidase (LOX) was negatively regulated by NFI-C2 and positively regulated by FoxF1, and upregulation of LOX following FoxF1 overexpression in mouse mammary epithelial cells increased in vitro cell invasion. In the nuclei of FoxF1-overexpressing cells, the phosphorylation of Smad2 decreased, while that of p38 increased. Depletion of LOX by RNAi enhanced phosphorylation of Smad2 by a focal adhesion kinase (FAK)-dependent mechanism. In addition, induced expression of FoxF1 in a non-malignant human mammary epithelial cell line showed that the increase in LOX transcription and the suppression of Smad2 activity are early effects of FoxF1.ConclusionThese data show that FoxF1 enhances invasion in a LOX-dependent manner, is involved in the regulation of Smad2 signaling, and that FoxF1 overexpression ultimately leads to activation of p38 MAPK signaling. These findings provide new insights into the regulation of signaling pathways known to be important during breast tumor progression.

[1]  M. Fernö,et al.  Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. , 2010, Cancer research.

[2]  G. Bjursell,et al.  Nuclear Factor 1-C2 Contributes to the Tissue-specific Activation of a Milk Protein Gene in the Differentiating Mammary Gland* , 2002, The Journal of Biological Chemistry.

[3]  Yi Li,et al.  GLIPR-2 Overexpression in HK-2 Cells Promotes Cell EMT and Migration through ERK1/2 Activation , 2013, PloS one.

[4]  P. Cowin,et al.  Choreographing Metastasis to the Tune of LTBP , 2011, Journal of Mammary Gland Biology and Neoplasia.

[5]  T. Kalin,et al.  Forkhead Box F1 Is Essential for Migration of Mesenchymal Cells and Directly Induces Integrin-Beta3 Expression , 2007, Molecular and Cellular Biology.

[6]  Charis Eng,et al.  Direct evidence for epithelial-mesenchymal transitions in breast cancer. , 2008, Cancer research.

[7]  R. Oleggini,et al.  Altered adhesion features and signal transduction in NRK-49F cells transformed by down-regulation of lysyl oxidase. , 2003, Biochimica et biophysica acta.

[8]  J. Settleman,et al.  EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling , 2012, Growth factors.

[9]  Kuan-Ting Lin,et al.  Serine Protease PRSS23 Is Upregulated by Estrogen Receptor α and Associated with Proliferation of Breast Cancer Cells , 2012, PloS one.

[10]  J. Taylor‐Papadimitriou,et al.  Branching morphogenesis of human mammary epithelial cells in collagen gels. , 1994, Journal of cell science.

[11]  Jenny G. Parvani,et al.  Noncanonical TGF-β Signaling During Mammary Tumorigenesis , 2011, Journal of Mammary Gland Biology and Neoplasia.

[12]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[13]  P. Carlsson,et al.  FREAC-1 contains a cell-type-specific transcriptional activation domain and is expressed in epithelial-mesenchymal interfaces. , 1998, Developmental biology.

[14]  Y. Sasaki,et al.  Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness , 2014, Oncogene.

[15]  G. Bjursell,et al.  Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells , 2006, Molecular and Cellular Biology.

[16]  S. Hanks,et al.  The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. , 2008, Molecular biology of the cell.

[17]  M. Hendrix,et al.  Hypoxia/reoxygenation: A dynamic regulator of lysyl oxidase‐facilitated breast cancer migration , 2008, Journal of cellular biochemistry.

[18]  Colin G. Johnson,et al.  The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer , 2010, Breast Cancer Research and Treatment.

[19]  K. O'Byrne,et al.  Human single-stranded DNA binding proteins are essential for maintaining genomic stability , 2013, BMC Molecular Biology.

[20]  Y. Ho,et al.  Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway , 2012, Breast Cancer Research and Treatment.

[21]  M. Hendrix,et al.  Differentially expressed genes associated with the metastatic phenotype in breast cancer , 1999, Breast Cancer Research and Treatment.

[22]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Carlsson,et al.  Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production , 2006, Development.

[24]  Pang-Kuo Lo,et al.  Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. , 2010, Cancer research.

[25]  M. Oike,et al.  Endothelium-dependent epithelial-mesenchymal transition of tumor cells: exclusive roles of transforming growth factor β1 and β2. , 2013, Biochimica et biophysica acta.

[26]  A. Rademaker,et al.  Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. , 2003, Cancer research.

[27]  L. Doyle,et al.  A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Kivirikko,et al.  Inactivation of the Lysyl Oxidase Gene Lox Leads to Aortic Aneurysms, Cardiovascular Dysfunction, and Perinatal Death in Mice , 2002, Circulation.

[29]  G. Tuszynski,et al.  Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. , 2004, The Journal of surgical research.

[30]  R. Ravazzolo,et al.  Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter , 2000, The Journal of Biological Chemistry.

[31]  D. A. Hanson,et al.  Focal adhesion kinase: in command and control of cell motility , 2005, Nature Reviews Molecular Cell Biology.

[32]  L. Tamagnone,et al.  Multifaceted role of neuropilins in cancer. , 2011, Current medicinal chemistry.

[33]  P. Carlsson,et al.  The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. , 2001, Development.

[34]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[35]  D. Kirschmann,et al.  Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells. , 2011, Neoplasia.

[36]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[37]  L. Tentori,et al.  Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness. , 2013, Oncology reports.

[38]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[39]  M. Hendrix,et al.  A molecular role for lysyl oxidase in breast cancer invasion. , 2002, Cancer research.

[40]  Y. Bae,et al.  Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. , 2013, Human pathology.

[41]  L. Machesky,et al.  WIP: WASP-interacting proteins at invadopodia and podosomes. , 2012, European journal of cell biology.

[42]  V. Brunton,et al.  E-cadherin–integrin crosstalk in cancer invasion and metastasis , 2013, Journal of Cell Science.

[43]  P. Carlsson,et al.  Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. , 2001, Development.

[44]  P. Carlsson,et al.  Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4 , 2007, Development.

[45]  G. Bjursell,et al.  The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy , 2003, Oncogene.

[46]  Michael K. Wendt,et al.  p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-β-mediated Metastasis through Regulation of Smad2/3 Activity* , 2009, The Journal of Biological Chemistry.

[47]  M. Weller,et al.  Modulation of TGF‐β activity by latent TGF‐β‐binding protein 1 in human malignant glioma cells , 2009, International journal of cancer.

[48]  A. Satelli,et al.  Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.

[49]  J. Erickson,et al.  Rho GTPases and their roles in cancer metabolism. , 2013, Trends in molecular medicine.

[50]  Y. Glinka,et al.  Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. , 2011, Carcinogenesis.

[51]  J. Whitsett,et al.  Foxf1 haploinsufficiency reduces Notch-2 signaling during mouse lung development. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[52]  M. Hendrix,et al.  Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. , 2005, Cancer research.

[53]  G. Tuszynski,et al.  Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion. , 2009, Experimental and molecular pathology.

[54]  G. Bell,et al.  Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy , 2012, Proceedings of the National Academy of Sciences.

[55]  J. Nesland,et al.  The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. , 2006, Gynecologic oncology.

[56]  J. Foekens,et al.  Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment. , 2000, Journal of the National Cancer Institute.

[57]  K. Edlund,et al.  Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. , 2010, Cancer research.

[58]  G. Breier,et al.  Overexpression of factor inhibiting HIF‐1 enhances vessel maturation and tumor growth via platelet‐derived growth factor‐C , 2012, International journal of cancer.

[59]  J. Schwarzbauer,et al.  Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition , 2013, Oncogene.

[60]  R. Assoian,et al.  ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition. , 2008, Cancer research.

[61]  F. Chibon,et al.  YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas , 2010, Genes, chromosomes & cancer.